Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Lymph Node Involvement as a Predictor for Cancer-Specific Survival in Patients with Penile Squamous Cell Cancer.
Kawase M, Takagi K, Kawada K, Ishida T, Tomioka M, Enomoto T, Fujimoto S, Taniguchi T, Ito H, Kameyama K, Yamada T, Kawase K, Kato D, Takai M, Iinuma K, Nakane K, Koie T. Kawase M, et al. Among authors: tomioka m. Curr Oncol. 2022 Aug 1;29(8):5466-5474. doi: 10.3390/curroncol29080432. Curr Oncol. 2022. PMID: 36005170 Free PMC article.
The utility of laparoscopic partial nephrectomy with renal function preservation, regardless of warm ischemia time, compared with laparoscopic radical nephrectomy.
Kato D, Nakane K, Enomoto T, Tomioka M, Nakai C, Takai M, Iinuma K, Muramatsu Maekawa Y, Mizutani K, Tsuchiya T, Yokoi S, Koie T. Kato D, et al. Among authors: tomioka m. Asian J Endosc Surg. 2021 Jul;14(3):386-393. doi: 10.1111/ases.12876. Epub 2020 Oct 8. Asian J Endosc Surg. 2021. PMID: 33034158
The Impact of Neutrophil-to-Lymphocyte Ratio after Two Courses of Pembrolizumab for Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma.
Tomioka-Inagawa R, Nakane K, Enomoto T, Tomioka M, Taniguchi T, Ishida T, Ozawa K, Takagi K, Ito H, Takeuchi S, Kawase M, Kawase K, Kato D, Takai M, Iinuma K, Yokoi S, Nakano M, Koie T. Tomioka-Inagawa R, et al. Among authors: tomioka m. Biomedicines. 2022 Jul 6;10(7):1609. doi: 10.3390/biomedicines10071609. Biomedicines. 2022. PMID: 35884914 Free PMC article.
Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma after Discontinuing Pembrolizumab as a Second-Line Treatment: A Retrospective Multicenter Real-World Cohort Study.
Yamada T, Nakane K, Enomoto T, Tomioka M, Taniguchi T, Ishida T, Ozawa K, Takagi K, Ito H, Takeuchi S, Kawase M, Kawase K, Kato D, Takai M, Iinuma K, Yokoi S, Nakano M, Koie T. Yamada T, et al. Among authors: tomioka m. Biomedicines. 2022 Sep 9;10(9):2243. doi: 10.3390/biomedicines10092243. Biomedicines. 2022. PMID: 36140344 Free PMC article.
228 results